Penserra Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-48,749
| Closed | -$3.02M | – | 1223 |
|
|
2023
Q4 | $3.02M | Buy |
+48,749
| New | +$3.02M | 0.06% | 221 |
|
|
2023
Q3 | – | Sell |
-64,291
| Closed | -$3.69M | – | 1242 |
|
|
2023
Q2 | $3.69M | Buy |
+64,291
| New | +$3.69M | 0.07% | 186 |
|
|
2022
Q2 | – | Sell |
-178,801
| Closed | -$6.42M | – | 1379 |
|
|
2022
Q1 | $6.42M | Buy |
+178,801
| New | +$6.42M | 0.15% | 163 |
|
|
2021
Q4 | – | Sell |
-1,100
| Closed | -$20K | – | 1358 |
|
|
2021
Q3 | $20K | Buy |
1,100
+15
| +1% | +$273 | ﹤0.01% | 1243 |
|
|
2021
Q2 | $21K | Buy |
1,085
+15
| +1% | +$290 | ﹤0.01% | 1131 |
|
|
2021
Q1 | $19K | Sell |
1,070
-20
| -2% | -$355 | ﹤0.01% | 975 |
|
|
2020
Q4 | $21K | Buy |
1,090
+686
| +170% | +$13.2K | ﹤0.01% | 841 |
|
|
2020
Q3 | $7K | Buy |
+404
| New | +$7K | ﹤0.01% | 846 |
|